Dealbreaker on MSN

Pfizer pockets $1.9B by offloading stake in HIV drugs company majority owned by GSK

Pfizer’s stake in ViiV Healthcare will be taken over by Shiongi, another minority shareholder in the HIV medicines company.
GEN - Genetic Engineering and Biotechnology News

GSK to Acquire Rapt for $2.2B, Adding Food Allergy Candidate to Pipeline

GlaxoSmithKline (GSK) has agreed to acquire Rapt Therapeutics for $2.2 billion, the companies said today, in a deal intended to bolster the buyer’s pipeline with Rapt’s ozureprubart (RPT904), a ...
Zacks Investment Research on MSN

BMY vs GSK: Which biopharma giant has better prospects for now?

Bristol Myers Squibb BMY and GSK PLC GSK are among the largest global biopharma companies with broad and diverse portfolios.
Fierce Pharma

Pfizer unleashes its stake in GSK's ViiV Healthcare for $1.9B

The New York powerhouse has agreed to surrender its 11.7% interest in the HIV-focused company for $1.875 billion. Under terms ...
The Motley Fool

Pharmaceutical tariffs: Which countries does the U.S. import the most from?

2024 US pharma trade deficit was $115.5B, with largest deficit of $45.5B with Ireland. Trump proposed 100% tariffs on certain pharma imports to encourage US drug manufacturing. US imports most ...